Charles River Laboratories

Cell and Gene Therapy CDMO Solutions

At Charles River Laboratories, they are passionate about their role in improving the quality of people’s lives. Their mission, their excellent science and their strong sense of purpose guide them in all that they do, and they approach each day with the knowledge that their work helps to improve the health and well-being of many across the globe.

Cell and Gene Therapy CDMO Solutions

Charles River has supported the development of 10 FDA-approved cell and gene therapies and conducted more than 900 studies in this field over the past year. Their unsurpassed end-to-end offering results in enhanced access to scientific and regulatory expertise via a multidisciplinary bench of experts to help you problem solve. At Charles River, the focus is on accelerating and achieving your critical development goals from discovery to commercialization. In June 2021, Charles River acquired Vigene Biosciences, a trusted leader in contract development and manufacturing solutions for gene therapy, to strengthen this goal.

Charles River offer innovative viral vector and plasmid products which can be leveraged to enhance your gene discovery research and programs. AAV reference materials are critical during manufacturing process development and comparison between studies and clinical trials. Viral vector controls can be used to measure transduction efficiency or as negative controls.

Plasmid and Viral Vector Products:

- AAV Products and Reference Materials (full and empty capsids)